Viatris Inc. Issues Nationwide Recall of Xanax Tablets Over Safety Concerns

Viatris Inc. has announced a voluntary recall of a specific lot of extended-release Xanax (alprazolam) tablets due to potential safety issues. This recall is significant as it affects consumers nationwide who rely on this medication for anxiety management. Patients are advised to check their prescriptions and return any affected tablets to their pharmacies. The recall aims to prevent any adverse health effects that may arise from the use of these specific tablets.

Key Details: • Check your prescriptions for affected Xanax tablets. • Return any recalled tablets to your pharmacy for a refund. • Stay informed about potential health risks associated with the recalled lot.